New Orleans BioFund

What New Orleans BioFund does

The New Orleans BioFund is the early-stage investment arm of the New Orleans BioInnovation Center (NOBIC), a Louisiana-incorporated nonprofit business incubator founded in 2011 (with BioFund investing from 2012). It provides flexible, founder-friendly equity capital to bioscience and health innovation startups, primarily in Louisiana and the Gulf South, alongside co-investors such as Gulf South Angels, the Community Development Venture Capital Alliance (CDVCA), Tulane Ventures, Boot64, and 1834 Ventures. Portfolio activity spans AI-driven diagnostics and neurotech (JuneBrain, Beken Bio, Informuta), reconstructive medicine (BioAesthetics), neurological drug-discovery platforms (AxoSim, now 28bio), fat-on-a-chip pharma tools (Obatala Sciences), safety incident software (Performance Health Partners, acquired by Sentact in January 2026), and CRISPR pathogen detection (Cleaved Diagnostics).

The BioFund is one element of a tightly integrated NOBIC offering that includes paid lab and office leasing in a 66,000-square-foot facility at 1441 Canal Street in the BioDistrict, shared core lab equipment (PCR, qPCR, microscopy, spectrometry), free commercialization consulting (business planning, IP assistance, market research, regulatory navigation), the BioFellows paid fellowship, and the annual BioChallenge global pitch competition awarding more than $100,000 in non-dilutive funding — currently themed around neurotech and brain health. The organization's revenue mechanics blend federal grants (notably $1.5M from the EDA Build to Scale Venture Challenge in 2020 and $500K from the EDA Build Back Better Regional Challenge in 2021), facility rental income, and the fund's own equity returns; grants and impact-driven funding from HUD and the Office of Community Development Disaster Recovery Unit kickstarted the BioFund at inception. The customer base is roughly 20+ early-stage portfolio companies plus incubator tenants, with no disclosed enterprise customers and no traditional SaaS or product revenue model.

Name

New Orleans BioFund

Legal name

New Orleans BioInnovation Center

Website

https://neworleansbio.com

Company type

Private

Founded year

2011

Operating status

Operating

Headcount range

1–10 employees

Short description

The New Orleans BioFund is an early-stage investment fund providing flexible equity capital to bioscience and health innovation startups in Louisiana, operating as the investment arm of the nonprofit New Orleans BioInnovation Center incubator.

Ownership category

akta.pro rank

Product category

Life Sciences Venture Capital / Biotech Incubator

NAICS

Open-End Investment Funds (52591), Grantmaking Foundations (813211)

SIC

Investment Advice (6282)

akta.pro primary industry

Healthcare Access & Life Sciences Impact Funds (FSANAJAI)

akta.pro secondary industries

Impact Investing & Social Finance (Funds, CDFIs, Microfinance) (BPAGALAA), Impact Investment & Development Investment Funds (BPADACAO)

Keywords

• Early-stage investment
• Bioscience funding
• Venture capital
• Life sciences incubator
• Commercialization services

Headquarters

HQ city

New Orleans

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Infrastructure, Others

Revenue model

1. Investment Returns: The BioFund generates returns through equity investments in early-stage bioscience companies. As a venture capital fund, it takes ownership stakes in portfolio companies and realizes returns through exits via acquisitions, IPOs, or secondary sales. The fund is part of a nonprofit incubator structure and combines financial returns with community impact objectives.
2. Co-Investment Revenue: The BioFund co-invests with other investors (such as CDVCA and Gulf South Angels) in portfolio companies, diversifying risk while maintaining involvement in promising startups.

Go-to-market motion2 records

Distribution channels2 records

Marketing channels6 records

Core offering

The New Orleans BioFund is an early-stage investment fund that deploys flexible, founder-friendly equity capital into Louisiana-based bioscience and health innovation companies, helping them hire specialized talent, purchase equipment, and reach key commercialization milestones. Capital is paired with strategic support through the New Orleans BioInnovation Center (NOBIC) ecosystem, which provides free commercialization consulting, shared core-lab equipment, wet-lab/office leasing, the BioFellows paid fellowship, and the annual BioChallenge pitch competition that awards more than $100,000 in non-dilutive funding. The fund co-invests alongside partners such as Gulf South Angels, CDVCA, and Tulane Ventures, and integrates community-economic-impact objectives alongside financial-return objectives as part of a nonprofit incubator structure.

Product overview

The New Orleans BioFund is an early-stage investment fund operating as part of the New Orleans BioInnovation Center (NOBIC), a nonprofit business incubator focused on advancing life science entrepreneurship and technology commercialization in Louisiana. The organization offers a suite of integrated products and services: the BioFund provides flexible investment capital to bioscience startups; the BioFellows Program offers a paid fellowship for those seeking experience at the intersection of biotech, venture capital, and startup building; the BioChallenge Pitch Competition is an annual global competition awarding non-dilutive funding to neuro-focused startups; Commercialization Consulting provides free services including business planning, IP assistance, and market research; Core Lab Equipment Access offers shared research instruments; and Lab/Office Space Leasing provides wet-lab and office facilities. Together, these offerings form a comprehensive support ecosystem for early-stage biotechnology companies from funding through commercialization.

Differentiator

Problem solved

Functional benefit

Brands

• BioChallenge: NOBIC's annual global pitch competition for early-stage life science startups, awarding non-dilutive funding to promising biotech, neurotech, and brain health companies.
• BioFellows

Products and services

• New Orleans BioFund An early-stage equity investment fund that provides flexible, founder-friendly funding to bioscience and health-innovation companies with strong economic and community impact potential in Louisiana; supports specialized talent hiring, equipment purchases, and reaching key commercialization milestones.
• BioFellows Program A paid fellowship positioned at the intersection of biotech, venture capital, and startup building. Fellows gain real-world startup knowledge, venture capital and investment analysis experience, professional mentorship, and networking opportunities while participating in NOBIC programs, events, BioFund investment support, and the BioChallenge global pitch competition.
• BioChallenge Pitch Competition An annual global pitch competition for life-sciences startup companies with cutting-edge technologies. Awards more than $100,000 in non-dilutive funding to neuro-focused startups working to address neurological diseases and advance brain health innovation; serves as a key deal-sourcing and visibility channel for the BioFund.
• Commercialization Consulting Services Free consulting services that assess promising new technologies and propel them toward market. Includes business planning, intellectual property assistance, market research, regulatory navigation, financing support, connections to external resources, and educational programming — offered to bioscience founders and startups.
• Lab and Office Space Leasing Leased wet-lab and office space in a 66,000-square-foot life-sciences incubator at 1441 Canal Street, New Orleans Medical District. Individual lab benches start at $1,000/month, lab suites begin at $5,500/month, and offices start at $1,000/month. Leases support biotech tenant companies of the BioInnovation Center.
• Event Space Rental Event and meeting space in New Orleans with a 100+-person conferencing center including state-of-the-art audiovisual equipment, a sunlit interior atrium, and a landscaped courtyard; supports receptions, parties, business meetings, and press conferences.
• Core Lab Equipment Access On-site access to cutting-edge shared-use research equipment worth more than $150,000, including PCR thermocyclers, qPCR systems, centrifuges, microscopes, spectrometers, and other bioscience research instruments. Available to tenant companies of the BioInnovation Center.

Quantifiable outcome

• Created or retained over 500 Full-Time-Equivalent Positions through BioFund Portfolio Companies
• +2 more outcomes

Named customers8 records

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Nine partnerships are on record, tiered core.

• UNT Health Fort WorthcoreGTM or Marketing PartnerUNT Health Fort Worth, under leadership of Dr. Sid O'Bryant, was presenting sponsor of BioChallenge 2025 and 2026 competitions, supporting the $100,000+ prize pool for neurotech startups.
• Ochsner HealthcoreStrategic or Co-development PartnerOchsner Health has provided early-stage capital and strategic healthcare system insight to NOBIC portfolio companies including Performance Health Partners and Obatala Sciences. Ochsner Ventures and Ochsner Lafayette General Foundation support startups through investment and partnership.
• Tulane UniversitycoreStrategic or Co-development PartnerTulane University is a key university partner providing research pipeline, innovation institute support, and spinout companies. NOBIC is led by board chair from Tulane.
• LSU Health New OrleanscoreStrategic or Co-development PartnerLSU Health Sciences Center is a university partner and board member, providing research talent and supporting biotech innovation for public good.
• Xavier University of LouisianacoreStrategic or Co-development PartnerXavier University of Louisiana is a university partner supporting the biotech ecosystem and workforce development. NOBIC partners with Xavier on initiatives including the Ochsner College of Medicine.
• University of New OrleanscoreStrategic or Co-development PartnerUNO houses the Advanced Materials Research Institute where portfolio companies like Obatala Sciences and Advano have located.
• BioDistrict New OrleanscoreStrategic or Co-development PartnerBioDistrict New Orleans is a state-enabled economic development district focused on expanding the biosciences sector. NOBIC is located within the BioDistrict at 1441 Canal Street.
• Louisiana Economic DevelopmentcoreStrategic or Co-development PartnerLED supports NOBIC and the state's biotech ecosystem through strategic partnerships and initiatives including the Louisiana Opportunity Capital program.
• Greater New Orleans Inc. (GNO Inc.)coreStrategic or Co-development PartnerGNO Inc. is a regional economic development organization that supports the Gulf Coast Health Sciences Corridor coalition and biotech ecosystem growth.

Scale indicators5 records

Recent moves11 records

Expansion highlights6 records

Direct peers

• LabCentral: Cambridge, MA-based nonprofit biotech incubator providing shared lab space, equipment, and programming to high-potential life science startups. Operates a similar 'fund + facility + community' model though anchored in a more mature biotech cluster.
• CDVCA (Community Development Venture Capital Alliance): National network of community development venture capital funds — directly comparable as an impact-focused VC fund focused on job creation in distressed communities, and an active co-investor alongside BioFund in portfolio companies like Informuta and Beken Bio.
• JumpStart Health: Cleveland-based healthcare and bioscience venture development organization (formerly BioEnterprise). Provides investment capital, advisory services, and ecosystem support to early-stage health companies — directly comparable model to BioFund's integrated approach.
• MBC BioLabs: San Francisco Bay Area biotech incubator offering fully equipped lab space, equipment access, and venture support to early-stage life science startups — comparable to NOBIC's physical infrastructure and value-add operating model, though at larger scale and in a richer ecosystem.
• Gulf South Angels: Regional angel investor network with 165 accredited investors across 18 states and $32M+ deployed across 70+ companies — direct co-investor with BioFund in JuneBrain, providing parallel early-stage capital across the Gulf South region with overlap in life sciences.
• BioGenerator: St. Louis-based nonprofit bioscience startup creation engine that combines seed/venture capital with lab space, equipment, and operating support — structurally identical to NOBIC/BioFund's regional bioscience incubator + investment fund model.

Broad incumbents

• IndieBio (SOSV): Global early-stage biotech accelerator and venture fund operating at significantly larger scale. Co-investor alongside BioFund in BioAesthetics' Series A; comparable focus on life science commercialization but with broader geographic reach and larger check sizes.
• Biolabs: International network of coworking and shared lab spaces for biotech startups across multiple U.S. and European cities — comparable to NOBIC's lab/office leasing offering at the facility level, though operating as a broader commercial platform.
• ARCH Venture Partners: Established early-stage biotech venture firm with broad life sciences thesis spanning therapeutics, diagnostics, and platforms. Operates at much larger scale than BioFund but addresses the same fundamental opportunity of funding early-stage life science companies.

Emerging players

• Biolocity: University-based translational fund and commercialization program supporting early-stage medical device and biotech innovations from Emory University and Georgia Tech — comparable in providing early-stage capital and support services to academic spinouts in regional ecosystems.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/NOLABioFund
• Facebookfacebook.com/neworleansbio
• LinkedInlinkedin.com/company/new-orleans-bioinnovation-center

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments27 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about New Orleans BioFund